source Post navigation Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study | Scientific Reports – Nature.com Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data – AJMC.com Managed Markets Network